The constant government changes that have taken place over the last three years, along with the general composition of the Knesset (Israel’s parliament) with multiple parties with different ideologies, makes predicting the future of Israel’s CBD sector difficult. CBD is no longer considered a scheduled substance and will be allowed in foods and cosmetics once approved by the Ministry of Health.
A new reform in medical cannabis is expected to enter into force in March 2024, which will ease the regulatory burden for patients and industry members.
This report provides a detailed overview of Israel’s regulatory framework for CBD, hemp and cannabis.
Mohamed brings more than four years of experience in the field of policy analysis. He has previously worked at Dow Jones & company as a research analyst. He is based in Barcelona, Spain; and holds a Master’s degree in Political Science from the ‘Universitat Autonoma de Barcelona’, and a Bachelor’s degree in Political Science from ‘Alexandria University’.
Our Key Benefits
The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.
CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.
Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organization
Thanks for getting in touch with us
Please leave your enquiry and we will get back to you within 24 hours
LATEST ALERTS
